Refine my results

Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors

Sessa, C. ; Cuvier, C. ; Caldiera, S. ; Bauer, J. ; Van den Bosch, S. ; Monnerat, C. ; Semiond, D. ; Pérard, D. ; Lebecq, A. ; Besenval, M. ; Marty, M.

In: Annals of Oncology, 2002, vol. 13, no. 7, p. 1140-1150